Related Experiment Video
Updated: May 6, 2026

Identification of Dopamine D1-Alpha Receptor Within Rodent Nucleus Accumbens by an Innovative RNA In Situ Detection Technology
Published on: March 27, 2018
Dopamine D1 sensitivity in the prefrontal cortex predicts general cognitive abilities and is modulated by working
Christopher Wass1, Alessandro Pizzo, Bruno Sauce
1Department of Psychology, Rutgers University, Piscataway, New Jersey 08854, USA.
General cognitive ability (GCA) in mice is linked to dopamine D1 receptor (D1R) neuron activation in the prelimbic cortex. Working memory training enhanced GCA and D1R neuron activation, suggesting D1R sensitivity is key.
Area of Science:
- Neuroscience
- Cognitive Science
- Animal Behavior
Background:
- General cognitive ability (GCA) is influenced by working memory and selective attention.
- Dopamine D1 receptor (D1R) signaling in the prefrontal cortex modulates attention.
Purpose of the Study:
- To investigate the relationship between GCA and D1R neuron activation in mice.
- To determine if working memory training impacts GCA and D1R signaling.
Main Methods:
- Assessed GCA in CD-1 mice using five diverse learning tests.
- Administered a D1 agonist (SKF82958) and measured c-Fos activation in D1R neurons.
- Analyzed D1R density via Western blot and evaluated effects of working memory training.
Main Results:
- High GCA mice showed increased D1R neuron activation in the prelimbic cortex post-agonist.
- No difference in D1R density was found between high and low GCA groups.
- Working memory training increased GCA and enhanced D1R-mediated activation in the prelimbic cortex.
Conclusions:
- D1R sensitivity, not density, in the prelimbic cortex may regulate GCA.
- Working memory training enhances GCA potentially by modulating D1R sensitivity.
Related Concept Videos
Role of Cerebellum and Prefrontal Cortex in Memory
Working Memory
Information Processing Approach
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

